|Articles|March 6, 2006
Medidata Solutions to Provide Clinical Data Management Expertise at 18th Annual DIA EuroMeeting
Chief Medical Officer Ed Ikeguchi to Present on UK’s Nationwide EDC Deployment; Senior Director Anne Zielinski to Highlight Data Integration Techniques
Advertisement
NEW YORK, NY – March 1, 2006 – Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced that Chief Medical Officer Dr. Ed Ikeguchi and newly-appointed Senior Director of Strategic Alliances Anne Zielinski will each be presenting at the 18th Annual DIA EuroMeeting to be held March 6–8, 2006 at Le Palais des Congres in Paris, France.
Ikeguchi's presentation, to be delivered on Wednesday, March 8th at 12:30 p.m., is entitled "The Deployment of Technology Platforms and Electronic Data Capture (EDC) on a National Level: Experience with the National Health Service (NHS) in the United Kingdom." In this seminar, Ikeguchi will present a case study of the UK's government-sponsored effort to improve clinical trials quality and stimulate enrollment through the NHS and the National Cancer Research Network (NCRN). Ikeguchi plans to discuss how standardizing technology as a single platform across an entire nation requires unique considerations for successful implementation.
Zielinski's presentation, "Importing and Exporting Data from EDC – Options and Experiences" on Wednesday, March 8th at 11:00 a.m., will illustrate how increased use of EDC has brought demands for integration of data from various sources. Attendees will learn how data has been integrated, what workflows have been used for integrated data, and how to avoid issues when integrating data.
At this year's show, Medidata Solutions will also be demonstrating its Rave electronic clinical data management solution at booth #55. In addition to showcasing technologies like Rave, the conference will offer attendees an opportunity to learn about the challenges of the revised pharmaceutical legislation and witness the release of the latest developments in important initiatives in Europe.
As one of Medidata's founders and the company's Chief Medical Officer, Ikeguchi focuses on regulatory compliance and 21 CFR Part 11 and is responsible for ensuring defined project goals, objectives, development strategy, resource requirements and scheduling. Prior to forming Medidata Solutions in 2000, Ikeguchi served as assistant professor of clinical urology at Columbia University and held hospital appointments at Columbia Presbyterian, Helen Hayes Hospital and White Plains Hospitals Center. Ikeguchi has served as a clinical investigator in numerous trials sponsored by both the industry and NIH, with experience in technology-based processes related to the pharmaceutical and biotechnology industries. Ikeguchi is a regularly featured presenter at DIA and other industry events.
Zielinski joined Medidata as senior director of strategic alliances in December of 2005. Zielinski had previously served as vice President of strategic alliances at CB Technologies and vice president of business development at WebMD. Zielinski brings 10 years of experience in the EDC industry and is a frequent presenter at key industry events including SCDM and DIA meetings.
Articles in this issue
over 19 years ago
Article
Biophage Pharma Signs an Exclusive Licensing Agreement with Melisa Diagnostics Ltd.over 19 years ago
Article
Cognitive Drug Research Signs Development Agreement With Pharma Services Networkover 19 years ago
Article
Phase Forward Shows Strong Presence at DIA 18th Annual EuroMeeting Conferenceover 19 years ago
Article
PRA International Names Dr. Cynthia Kirk Vice President of Global Regulatory AffairsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
2
Phase III BRUIN CLL-313 Trial Finds Jaypirca Extends Progression-Free Survival in Treatment-Naïve CLL/SLL
3
Latest NIMBLE Study Results Highlight Progress in gMG Research
4
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
5